↓ Skip to main content

Dove Medical Press

Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma

Overview of attention for article published in OncoTargets and therapy, May 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
1 patent

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
17 Mendeley
Title
Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma
Published in
OncoTargets and therapy, May 2013
DOI 10.2147/ott.s44406
Pubmed ID
Authors

Yan Shi, Qin, Wang, Dai

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 18%
Other 2 12%
Student > Ph. D. Student 2 12%
Professor > Associate Professor 2 12%
Student > Doctoral Student 1 6%
Other 5 29%
Unknown 2 12%
Readers by discipline Count As %
Medicine and Dentistry 7 41%
Agricultural and Biological Sciences 3 18%
Pharmacology, Toxicology and Pharmaceutical Science 2 12%
Unspecified 1 6%
Chemistry 1 6%
Other 1 6%
Unknown 2 12%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2020.
All research outputs
#7,524,294
of 22,962,258 outputs
Outputs from OncoTargets and therapy
#471
of 2,946 outputs
Outputs of similar age
#65,346
of 193,438 outputs
Outputs of similar age from OncoTargets and therapy
#18
of 38 outputs
Altmetric has tracked 22,962,258 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,946 research outputs from this source. They receive a mean Attention Score of 2.6. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,438 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.